Las Vegas, NV -- (SBWIRE) -- 10/05/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Sequenom, Inc. (NASDAQ:SQNM), Tenet Healthcare Corp (NYSE:THC), Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX)
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) managed to keep its gain at 1.45% on below -normal volume of 2.63M shares. The stock settled at $38.46 after floating in a range of $37.77 to $38.50. Its latest price has reached market capitalization of $32.50 billion. Its 52-week range has been $36.63 to $42.83. Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide.
For How Long TEVA will fight for Profitability? Read This Trend Analysis report
Sequenom, Inc. (NASDAQ:SQNM) traded down on a volume of 2.59 million, higher than its standard daily volume. Shares have dropped-2.63 % to $2.59. Over the last twelve months, the stock has lost-26.63% and faced a worst price of $2.58. Sequenom, Inc., a life sciences company, provides genetic analysis solutions in the United States and internationally. It operates through two segments, Molecular Diagnostics and Genetic Analysis.
Has SQNM Found The Bottom And Ready To Gain Momentum? Find Out Here
Tenet Healthcare Corp (NYSE:THC) settled -0.37% lower at $46.10 on above-normal volume of 2.49M shares during the last trading day. The stock has its 12-month high at $49.47 and 52-week low price was $22.86. It traded in a range of $45.61 to $47.05 during the last trading day. Tenet Healthcare Corporation, an investor-owned health care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, urgent care centers, and related health care facilities in the United States.
Will THC Get Buyers Even After The Recent Rally?
In the last trading session, Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) was down on low volume, trading at a volume of 2.46M versus its average daily volume of 3.03 million shares. At $3.28, the stock has attained market capitalization of 173.49 million. Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company.
Why Should Investors Buy CPRX After the Recent Fall? Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)